Increased fibrinogen, D-dimer and galectin-3 levels in patients with migraine

Neurological Sciences

Volumn 35, Issue 4, 2014, Pages 545-549

  Yucel, Yavuz ^a   Tanriverdi, Halis ^a   Arikanoglu, Adalet ^a   Varol, Sefer ^a   Kaplan, Ibrahim ^a   Akil, Esref ^a   Celepkolu, Tahsin ^a   Uzar, Ertugrul ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

d Dimer; Fibrinogen; Galectin 3; Migraine; Pathogenesis

Indexed keywords

D DIMER; FIBRINOGEN; GALECTIN 3;

ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROGENIC INFLAMMATION; PATHOGENESIS;

ADULT; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; GALECTIN 3; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 84897062195     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1542-2     Document Type: Article

References (30)

1. Ferrara M, Capozzi L, Bertocco F, Ferrara D, Russo R (2012) Thrombophilic gene mutations in children with migraine. Hematology 17:115-117. doi:10.1179/102453312X13221316478010
2. Martinez-Sanchez P, Martinez-Martinez M, Fuentes B, Cuesta MV, Cuellar-Gamboa L, Idrovo-Freire L, Fernandez-Dominguez J, Diez-Tejedor E (2011) Migraine and hypercoagulable states in ischemic stroke. Cephalalgia: Int J Headache 31:1609-1617. doi:10.1177/0333102411427599
3. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914. doi:10.1136/bmj.b3914
4. Isobe C, Terayama Y (2010) A remarkable increase in total homocysteine concentrations in the CSF of migraine patients with aura. Headache 50:1561-1569. doi:10.1111/j.1526-4610.2010.01713.x
5. Termine C, Trotti R, Ondei P, Gamba G, Montani N, Gamba A, De Simone M, Marni E, Balottin U (2010) Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. Acta Neurol Scand 122:91-96. doi:10.1111/j.1600-0404.2009.01268.x
6. Walkowiak B, Kozubski W, Pawlowska Z, Prusinski A, Cierniewski CS (1989) Expression of fibrinogen receptors in platelets of migraine patients-correlation with platelet GPIIb content and plasma cholesterol. Thromb Haemost 61:419-422 (Pubitemid 19168148)
7. Stoppa-Vaucher S, Dirlewanger MA, Meier CA, de Moerloose P, Reber G, Roux-Lombard P, Combescure C, Saudan S, Schwitzgebel VM (2012) Inflammatory and prothrombotic states in obese children of European descent. Obesity (Silver Spring) 20:1662-1668. doi:10.1038/oby.2012.85
8. Hirano K, Takashima S, Dougu N, Taguchi Y, Nukui T, Konishi H, Toyoda S, Kitajima I, Tanaka K (2012) Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype. J Stroke Cerebrovasc Dis: Off J Natl Stroke Assoc 21:404-410. doi:10.1016/j.jstrokecerebrovasdis.2011.08.013
9. Kurth T, Ridker PM, Buring JE (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia: Int J Headache 28:49-56. doi:10.1111/j.1468-2982.2007.01467.x (Pubitemid 350212655)
10. Shin T (2013) The pleiotropic effects of galectin-3 in neuroinflammation: a review. Acta Histochem. doi:10.1016/j.acthis.2012.11.010
11. Fernandez GC, Ilarregui JM, Rubel CJ, Toscano MA, Gomez SA, Beigier Bompadre M, Isturiz MA, Rabinovich GA, Palermo MS (2005) Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology 15:519-527. doi:10.1093/glycob/cwi026 (Pubitemid 41214397)
12. Olesen J (2005) The international classification of headache disorders, 2nd edition: application to practice. Funct Neurol 20:61-68
13. Takagi H, Manabe H, Kawai N, Goto S, Umemoto T (2009) Plasma fibrinogen and D-dimer concentrations are associated with the presence of abdominal aortic aneurysm: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg: Off J Eur Soc Vasc Surg 38:273-277. doi:10.1016/j.ejvs.2009.05.013
14. de Almeida VV, Silva-Herdade A, Calado A, Rosario HS, Saldanha C (2012) Fibrinogen modulates leukocyte recruitment in vivo during the acute inflammatory response. Clin Hemorheol Microcirc. doi:10.3233/CH-121660
15. Davalos D, Akassoglou K (2012) Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 34:43-62. doi:10.1007/s00281-011- 0290-8
16. Farrell DH (2012) gamma' Fibrinogen as a novel marker of thrombotic disease. Clin Chem Lab Med: CCLM/FESCC 50:1903-1909. doi:10.1515/cclm-2012-0005
17. Rudnicka AR, Mt-Isa S, Meade TW (2006) Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial. J Thromb Haemostasis : JTH 4:2405-2410. doi:10.1111/j.1538-7836.2006. 02221.x (Pubitemid 44575436)
18. Wannamethee SG, Whincup PH, Lennon L, Rumley A, Lowe GD (2012) Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men. Stroke J Cerebral Circ 43:1206-1211. doi:10.1161/STROKEAHA.111.636373
19. Tripodi A (2011) D-Dimer testing in laboratory practice. Clin Chem 57:1256-1262. doi:10.1373/clinchem.2011.166249
20. Zhou D, Yang PY, Zhou B, Rui YC (2007) Fibrin D-dimer fragments enhance inflammatory responses in macrophages: role in advancing atherosclerosis. Clin Exp Pharmacol Physiol 34:185-190. doi:10.1111/j.1440-1681.2007.04570.x (Pubitemid 46148260)
21. Bianchi A, Pitari G, Amenta V, Giuliano F, Gallina M, Costa R, Ferlito S (1996) Endothelial, haemostatic and haemorheological modifications in migraineurs. Artery 22:93-100 (Pubitemid 26286296)
22. Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E (2011) Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem 44:832-837. doi:10.1016/j.clinbiochem.2011.04.015
23. Walkowiak B, Kozubski W, Prusinski A, Cierniewski CS (1989) The increased contents of beta-thromboglobulin and fibrinogen in migraine platelets indicate an abnormality in thrombopoiesis. Headache 29:257 (Pubitemid 20346778)
24. Wesley UV, Vemuganti R, Ayvaci ER, Dempsey RJ (2013) Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Res 1496:1-9. doi:10.1016/j.brainres. 2012.12.008
25. Satoh K, Niwa M, Binh NH, Nakashima M, Kobayashi K, Takamatsu M, Hara A (2011) Increase of galectin-3 expression in microglia by hyperthermia in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia. Neurosci Lett 504:199-203. doi:10.1016/j.neulet.2011.09.015
26. Doverhag C, Hedtjarn M, Poirier F, Mallard C, Hagberg H, Karlsson A, Savman K (2010) Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 38:36-46. doi:10.1016/j.nbd.2009.12.024
27. Yan YP, Lang BT, Vemuganti R, Dempsey RJ (2009) Galectin-3 mediates post-ischemic tissue remodeling. Brain Res 1288: 116-124. doi:10.1016/j. brainres.2009.06.073
28. Jeon SB, Yoon HJ, Chang CY, Koh HS, Jeon SH, Park EJ (2010) Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J Immunol 185:7037-7046. doi:10.4049/jimmunol.1000154
29. Williamson DJ, Hargreaves RJ (2001) Neurogenic inflammation in the context of migraine. Microsc Res Tech 53:167-178. doi:10.1002/jemt.1081 (Pubitemid 32378031)
30. Chen HY, Sharma BB, Yu L, Zuberi R, Weng IC, Kawakami Y, Kawakami T, Hsu DK, Liu FT (2006) Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. J Immunol 177:4991-4997 (Pubitemid 44527568)